| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -552,756 | -549,164 |
| Net (decrease) increase in cash and cash equivalents | -577,825 | -624,777 |
| Effect of exchange rate changes on cash | 5,747 | - |
| Cash and cash equivalents at beginning of period | 1,298,327 | - |
| Cash and cash equivalents at end of period | 726,249 | - |
Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC)